We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automated Cholesterol Test Showcased for Cardiologists

By LabMedica International staff writers
Posted on 19 Apr 2011
An expanded lipid profile assay performed on whole blood has been demonstrated to heart specialist at a conference using qualified attendees own samples. More...


The blood test directly measures low-density lipoprotein (LDL) cholesterol (LDLc), without the patient having to fast, as well as 22 other cholesterol components.

The Vertical Auto Profile (VAP) Cholesterol Test components include lipoprotein A, (Lp(a)), apolipoprotein B, (apoB), apolipoprotein A1,(ApoA1), and the apoB/apoA1 ratio, making the VAP Test the only lipid profile that routinely reports all three lipid parameters, LDL, non-high-density lipoprotein (HDL) and apoB. These three lipid parameters are considered essential diagnostic parameters by the American College of Cardiology (ACC, Washington DC, USA), and the American Diabetes Association (Alexandria, VA, USA).

The comprehensive lipid profile also identifies markers of metabolic syndrome, often associated with early diabetes. The VAP Cholesterol Test is produced by Atherotech Diagnostics Lab (Birmingham, AL, USA), and provides clinicians with a single source for more than a dozen cardiovascular and metabolic tests. These include: high sensitivity C-reactive protein (hsCRP), lipoprotein-associated phospholipase A2 (LpPLA2), apolipoprotein E (apoE) genotype, the N-terminal prohormone of brain natriuretic peptide (NT-proBNP), cystatin C, triiodothyronine (T3) and thyroxine (T4) when the thyroid-stimulating hormone (TSH) is abnormal, and gamma-glutamyl transferase (GGT), a recognized cardiovascular risk biomarker.

The VAP Cholesterol Test was exhibited to participants at the American College of Cardiology's 60th Annual Scientific Sessions held April 2-5, 2011, in New Orleans, LA, USA. Michael V. Mullen, president and chief executive officer of Atherotech, said,"Atherotech invited ACC attendees to learn about our battery of cardiodiagnostic tests and learn firsthand the predictive power of the VAP Test."

Related Links:
Atherotech Diagnostics Lab
American College of Cardiology
American Diabetes Association



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.